Clinical Trial Update: MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

View source ↗

Summary

The MICRO2 trial evaluating magnetocardiography (MCG) as a noninvasive diagnostic strategy for suspected INOCA has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Microvascular Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Snippet

Sponsor: Genetesis Inc. | Conditions: Ischemic Heart Disease, Coronary Microvascular Disease | Status: COMPLETED